Phytohealth Corp (4108) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.005x

Based on the latest financial reports, Phytohealth Corp (4108) has a cash flow conversion efficiency ratio of 0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$11.18 Million ≈ $352.14K USD) by net assets (NT$2.27 Billion ≈ $71.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Phytohealth Corp - Cash Flow Conversion Efficiency Trend (2005–2024)

This chart illustrates how Phytohealth Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Phytohealth Corp carry for a breakdown of total debt and financial obligations.

Phytohealth Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Phytohealth Corp ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Datagate Bilgisayar Malzemeleri Ticaret AS
IS:DGATE
1.726x
RoyalTek Co Ltd
TWO:3306
-0.005x
Maat Pharma SA
PA:MAAT
-1.853x
Pelthos Therapeutics Inc.
NYSE MKT:PTHS
-0.161x
TEKNA HOLDING ASA NK 2
F:8VB
N/A
Gabriel Holding
CO:GABR
0.144x
Gossamer Bio Inc
NASDAQ:GOSS
0.439x
An Gia Real Estate Investment and Development Corp
VN:AGG
-0.167x

Annual Cash Flow Conversion Efficiency for Phytohealth Corp (2005–2024)

The table below shows the annual cash flow conversion efficiency of Phytohealth Corp from 2005 to 2024. For the full company profile with market capitalisation and key ratios, see Phytohealth Corp (4108) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 NT$2.37 Billion
≈ $74.62 Million
NT$-50.13 Million
≈ $-1.58 Million
-0.021x +12.24%
2023-12-31 NT$2.27 Billion
≈ $71.54 Million
NT$-54.77 Million
≈ $-1.73 Million
-0.024x +8.36%
2022-12-31 NT$2.28 Billion
≈ $71.75 Million
NT$-59.95 Million
≈ $-1.89 Million
-0.026x +7.86%
2021-12-31 NT$2.39 Billion
≈ $75.25 Million
NT$-68.24 Million
≈ $-2.15 Million
-0.029x +67.11%
2020-12-31 NT$1.70 Billion
≈ $53.63 Million
NT$-147.87 Million
≈ $-4.66 Million
-0.087x -25.30%
2019-12-31 NT$1.75 Billion
≈ $55.19 Million
NT$-121.45 Million
≈ $-3.83 Million
-0.069x +4.67%
2018-12-31 NT$1.94 Billion
≈ $61.27 Million
NT$-141.44 Million
≈ $-4.46 Million
-0.073x +0.29%
2017-12-31 NT$2.08 Billion
≈ $65.45 Million
NT$-151.52 Million
≈ $-4.77 Million
-0.073x +77.69%
2016-12-31 NT$2.32 Billion
≈ $72.95 Million
NT$-756.87 Million
≈ $-23.85 Million
-0.327x -472.14%
2015-12-31 NT$2.30 Billion
≈ $72.36 Million
NT$-131.22 Million
≈ $-4.13 Million
-0.057x -304.42%
2014-12-31 NT$2.39 Billion
≈ $75.25 Million
NT$-33.74 Million
≈ $-1.06 Million
-0.014x +68.58%
2013-12-31 NT$2.74 Billion
≈ $86.30 Million
NT$-123.18 Million
≈ $-3.88 Million
-0.045x +23.87%
2012-12-31 NT$2.78 Billion
≈ $87.67 Million
NT$-164.37 Million
≈ $-5.18 Million
-0.059x +46.05%
2011-12-31 NT$1.56 Billion
≈ $49.24 Million
NT$-171.09 Million
≈ $-5.39 Million
-0.109x -3.32%
2010-12-31 NT$1.82 Billion
≈ $57.41 Million
NT$-193.06 Million
≈ $-6.08 Million
-0.106x -98.88%
2009-12-31 NT$2.01 Billion
≈ $63.36 Million
NT$-107.15 Million
≈ $-3.38 Million
-0.053x -181.31%
2006-12-31 NT$1.32 Billion
≈ $41.63 Million
NT$86.57 Million
≈ $2.73 Million
0.066x +30.10%
2005-12-31 NT$1.19 Billion
≈ $37.44 Million
NT$59.85 Million
≈ $1.89 Million
0.050x --

About Phytohealth Corp

TW:4108 Taiwan Drug Manufacturers - Specialty & Generic
Market Cap
$75.72 Million
NT$2.40 Billion TWD
Market Cap Rank
#20305 Global
#1201 in Taiwan
Share Price
NT$12.10
Change (1 day)
+0.83%
52-Week Range
NT$12.00 - NT$17.30
All Time High
NT$46.36
About

PhytoHealth Corporation researches, develops, manufactures, and sells medicines, cosmetics, Class B medicines, complementary foods, and other related products in Taiwan. It operates in three segments: Medicines and Health Food, Medical Diagnosis, and Precision Medical Equipment and Instruments. The Medicines and Health Food segment manufactures and sells Chinese medicine materials and new drugs. … Read more